Tower Research Capital (TRC)’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10	Closed	-$1K	–	4915
2016 Q3	$1K	Buy	+10	New	+$1.3K	﹤0.01%	3503
2015 Q4	–	Sell	-10	Closed	-$1K	–	5534
2015 Q3	$1K	Sell	10 -4	-29%	-$607	﹤0.01%	3817
2015 Q2	$2K	Buy	+14	New	+$1.86K	﹤0.01%	3883

Tower Research Capital (TRC)'s AMSGP Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 10 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in AMSGP in Q2 2015 and held it in 3 quarters. The position peaked at $2K in Q2 2015. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

Tower Research Capital (TRC) reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 10 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q2 2015 and held it in 3 quarters.
Tower Research Capital (TRC)'s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $2K in Q2 2015.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.